5 Years Mortality-rate in Patients Treated for Severe Pneumonia in an ICU - a Retrospective Study
NCT ID: NCT02212093
Last Updated: 2015-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
236 participants
OBSERVATIONAL
2014-06-30
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survival Rates and Longterm Outcomes After COVID-19
NCT04601090
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
NCT01068990
Outcome Factors of Pneumonia Patients in Critical Care Unit
NCT05899192
Longitudinal Prospective Study in a Mixed ICU Population
NCT03714230
Lung and Systemic Inflammation in the Critically Ill Patient
NCT01906229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We are going to investigate the 5 years mortality rate in this population of patients. We are also going to investigate the cause of death in the patients who are discharged from the hospital alive.
Inclusion criteria: Patients \> 18 years. Primary diagnose: pneumonia, and the need of mechanical ventilation for at least 24 hours in an ICU. The patients who arrive at the ICU in Akershus University Hospital in the period from 01.01.1997 to 31.12.2006.
The datas are collected from the patients' journals and the local ICU register. Collecting data: Age, sex, comorbidity, SAPSII, mechanical ventilation time, stay in the ICU, stay in the hospital, ICU mortality, hospital mortality, 5 years mortality, type of pneumonia (bacteriology).
Time of death after discharge is collected from Norwegian National Registry. Cause of death after discharge is collected from Norwegian Institute of Public Health.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pneumonia and mechanical ventilation
The data are collected retrospectively from this one group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
University Hospital, Akershus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vegard Dahl
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vegard Dahl, Professor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Akershus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akershus University Hospital
Nordbyhagen, Akershus, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/2338
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.